DK1155696T3 - Anvendelse af olanzapin til fremstillingen af et medikament til neurobeskyttelse - Google Patents

Anvendelse af olanzapin til fremstillingen af et medikament til neurobeskyttelse

Info

Publication number
DK1155696T3
DK1155696T3 DK01202986T DK01202986T DK1155696T3 DK 1155696 T3 DK1155696 T3 DK 1155696T3 DK 01202986 T DK01202986 T DK 01202986T DK 01202986 T DK01202986 T DK 01202986T DK 1155696 T3 DK1155696 T3 DK 1155696T3
Authority
DK
Denmark
Prior art keywords
olanzapine
neuroprotection
drug
manufacture
Prior art date
Application number
DK01202986T
Other languages
English (en)
Inventor
Franklin Porter Bymaster
Gary Dennis Tollefson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from EP98302789A external-priority patent/EP0872238B1/en
Application granted granted Critical
Publication of DK1155696T3 publication Critical patent/DK1155696T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01202986T 1997-04-15 1998-04-09 Anvendelse af olanzapin til fremstillingen af et medikament til neurobeskyttelse DK1155696T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4309497P 1997-04-15 1997-04-15
EP98302789A EP0872238B1 (en) 1997-04-15 1998-04-09 Use of olanzapine for the manufacture of a medicament for neuroprotection

Publications (1)

Publication Number Publication Date
DK1155696T3 true DK1155696T3 (da) 2004-07-12

Family

ID=26151210

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01202986T DK1155696T3 (da) 1997-04-15 1998-04-09 Anvendelse af olanzapin til fremstillingen af et medikament til neurobeskyttelse

Country Status (2)

Country Link
EP (1) EP1155696B1 (da)
DK (1) DK1155696T3 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003101997A1 (en) 2002-05-31 2003-12-11 Geneva Pharmaceuticals, Inc. Process of preparation of olanzapine form i

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
ZA982917B (en) * 1997-04-15 1999-10-06 Lilly Co Eli Method for treating cerebral focal stroke.

Also Published As

Publication number Publication date
EP1155696A2 (en) 2001-11-21
EP1155696A3 (en) 2002-05-22
EP1155696B1 (en) 2004-03-03

Similar Documents

Publication Publication Date Title
DK0831097T3 (da) Olanzapindihydrat D
EE03801B1 (xx) Stent
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
NO20001160D0 (no) Nytt skumdannende farmasøytisk preparat
DE60040876D1 (de) Medikamentenzuführeinrichtung
DE69942666D1 (de) Intraluminaler stent
EE9900422A (xx) Stent
EE9900449A (xx) Stent
DE59802830D1 (de) Orthesengelenk
NO20001375D0 (no) Legemiddelformulering med kontrollert virkestoffrigivning
DE69820630D1 (de) Sprunggelenkstütze
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0899285T3 (da) Copolyester til stöbning af flasker
DE60013541D1 (de) Keramischer stiftheizer mit integrieten anschlusskontakten und verfahren zu dessen herstellung
DE69829006D1 (de) Triphendioxazinverbindungen
DE69837644D1 (de) Plastifizierschnecke
DK0971931T3 (da) Fremgangsmåde itl debenzylering af dibenzylbiotin
FR2767673B1 (fr) Prothese uretrale
DK1155696T3 (da) Anvendelse af olanzapin til fremstillingen af et medikament til neurobeskyttelse
DE59809195D1 (de) Gebläsebrenner
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK0855379T3 (da) Fremgangsmåde til fremstilling af benzophenonderivater
DK0862197T3 (da) Sikringsstik
DE59805673D1 (de) Formwerkzeug